China Pharma Holdings, Inc.
CPHI · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $5,839 | $85,788 | $40,690 |
| - Cash | $268 | $625 | $413 | $627 |
| + Debt | $128 | $3,426 | $3,506 | $3,591 |
| Enterprise Value | – | $8,640 | $88,882 | $43,655 |
| Revenue | $756,217,000 | $1,026 | $1,136 | $1,134 |
| % Growth | 73,722,002.6% | -9.7% | 0.2% | – |
| Gross Profit | -$59,654,000 | -$87 | -$136 | -$56 |
| % Margin | -7.9% | -8.5% | -12% | -4.9% |
| EBITDA | $378,773,350 | -$180 | -$428 | -$747 |
| % Margin | 50.1% | -17.6% | -37.7% | -65.8% |
| Net Income | -$651,482,000 | -$528 | -$786 | -$1,224 |
| % Margin | -86.2% | -51.5% | -69.1% | -108% |
| EPS Diluted | -0.17 | -0.16 | -0.18 | -0.26 |
| % Growth | -6.3% | 11.1% | 30.8% | – |
| Operating Cash Flow | -$237 | $291 | -$58 | $238 |
| Capital Expenditures | -$1 | -$10 | -$81 | -$273 |
| Free Cash Flow | -$238 | $281 | -$139 | -$34 |